Heron Therapeutics, Inc. - Common Stock (NQ:HRTX)

0.3588 +0.0112 (+3.22%)

Delayed Quote Updated: 2:08 PM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Heron Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >

18 Key Biopharma Catalysts To Keep An Eye On In Q3 ↗

July 10, 2021

Biopharma stocks underperformed in the first half of 2021, and several of these stocks could be in for a rebound in the coming months. Ne...

Via Benzinga

10 Health Care Stocks Showing Unusual Options Activity In Today's Session ↗

June 21, 2021

This unusual options alert can help traders track potentially big trading opportunities. Traders often look for circumstances when the market estimation of an option diverges away...

Via Benzinga

Under Biden's Budget, These 2 Little-Known Biotechs Could Help End the Opioid Crisis ↗

June 02, 2021

The White House's plans to address the U.S. opioid crisis could be good news for Heron Therapeutics and Collegium Pharmaceutical, makers of safer pain management drugs.

Via The Motley Fool

Topics Death

12 Health Care Stocks Moving In Friday's After-Market Session ↗

May 21, 2021

Gainers Sio Gene Therapies (NASDAQ:SIOX) ...

Via Benzinga

74 Biggest Movers From Friday ↗

May 17, 2021

Gainers MoSys, Inc. (NASDAQ: MOSY) shares climbed 50.5% to settle at $4.35 on Friday. MoSys, last week, reported a loss for its first quarter. HyreCar Inc. (NASDAQ: HYRE) shares...

Via Benzinga

The Week Ahead In Biotech: Sanofi, Bristol-Myers Squibb Await FDA Decisions, Earnings News Flow Tapers Off ↗

May 15, 2021

Biotech stocks had a volatile ride in the week ended May 14, with stocks moving lower for much of the week before coming back up strongly in the final session. Some of the weakness may be traced back...

Via Talk Markets

The Week Ahead In Biotech: Sanofi, Bristol-Myers Squibb Await FDA Decisions, Earnings News Flow Tapers Off ↗

May 15, 2021

Biotech stocks had a volatile ride in the week ended May 14, with stocks moving broadly lower for much of the week before coming back up strongly in the final session. Some of the...

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

May 14, 2021

Gainers Atea Pharmaceuticals (NASDAQ:AVIR) stock moved upwards by 24.11% to $23.86 during Friday's regular session. The current volume of 967.7K shares is 156.13% of...

Via Benzinga

Heron's Non-Opioid, Post-Operative Pain Drug Approved By FDA: Why This Is Important ↗

May 13, 2021

Shares of Heron Therapeutics Inc (NASDAQ: HRTX) are higher after a long wait to get regulatory approval for its non-opioid pain drug. What Happened: San Diego,...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

May 13, 2021

Gainers Palisade Bio (NASDAQ:PALI) shares moved upwards by 35.23% to $7.1 during Thursday's pre-market session. Lianluo Smart (NASDAQ:LLIT) shares rose 19.37% to $7.21...

Via Benzinga

The Daily Biotech Pulse: Minerva, InflaRx Report Positive Data Readouts, Lucira COVID-19 Test Kit Available On Amazon, Decision Day For Heron ↗

May 12, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 11) HOOKIPA Pharma Inc. (NASDAQ...

Via Benzinga

64 Biggest Movers From Yesterday ↗

May 11, 2021

Gainers InnSuites Hospitality Trust (NYSE: IHT) shares jumped 82.6% to settle at $6.39 on Monday. Protagenic Therapeutics, Inc. (NASDAQ: PTIX) shares surged 53.5% to close at $3....

Via Benzinga

Why Heron Therapeutics Stock Jumped Today ↗

May 10, 2021

Investors liked the company's Q1 update.

Via The Motley Fool

Heron Stock Trading Higher After Q1 Earnings, Ahead Of HTX-011 Decision Scheduled This Week ↗

May 10, 2021

Heron Therapeutics Inc (NASDAQ: HRTX) posted Q1 oncology care net product sales of $20 million, compared to $25.4 million a year ago, due to reduced cancer...

Via Benzinga

40 Stocks Moving In Monday's Mid-Day Session ↗

May 10, 2021

Gainers Protagenic Therapeutics, Inc. (NASDAQ: PTIX) shares jumped 64.2% to $3.4962 on above-average news. Obalon Therapeutics, Inc. (NASDAQ: OBLN) gained 35% to $2.97. Cue...

Via Benzinga

Want to Make Money in Biotech? Do This First ↗

May 07, 2021

Keeping track of upcoming events is important.

Via The Motley Fool

Topics Regulatory Compliance

Attention Biotech Investors: Mark Your Calendar For May PDUFA Dates ↗

May 01, 2021

Following a mixed month in April, the Food and Drug Administration sets out to review another slate of drugs in May. ACADIA Pharmaceuticals Inc.'s (NASDAQ: ACAD) Nuplazid...

Via Benzinga

The Week Ahead In Biotech (May 9-15): Heron, Apellis FDA Decisions, Presentations and Earnings ↗

May 09, 2021

Biotech stocks came under pressure in the week ended May 7 as traders digested a slew of earnings news flow and a handful of clinical trial readouts. COVID-19 vaccine stocks came...

Via Benzinga

10 Health Care Stocks Showing Unusual Options Activity In Today's Session ↗

April 28, 2021

This unusual options alert can help traders discover the next big trading opportunities. Traders will search for circumstances when the market estimation of an option diverges...

Via Benzinga

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.